Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults.
about
The role of gender in patients with diffuse large B cell lymphoma treated with rituximab-containing regimens: a meta-analysisCladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patientsCladribine in the treatment of chronic lymphocytic leukemia.Chronic lymphocytic leukaemia--the haematologic basis for diagnosis and treatment.The roles of age and sex in the prognosis of chronic leukaemias. A study of 373 cases.Splenectomy in lymphoproliferative disorders: a report on 70 cases and review of the literature.The clinical significance of patients' sex in chronic lymphocytic leukemia.Chronic lymphocytic leukaemia: a-twenty-years experience and problems in Ile-Ife, South-Western Nigeria.Predicting survival in chronic lymphocytic leukemia.Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective study.Improving but inferior survival in patients with chronic lymphocytic leukemia in taiwan: a population-based study, 1990-2004.B-chronic lymphocytic leukemia: practical aspects.Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia.Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cellsHypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes.Sex differences in incidence and outcome of chronic lymphocytic leukemia patients.B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome.Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia.Improved survival for patients diagnosed with chronic lymphocytic leukemia in the era of chemo-immunotherapy: a Danish population-based study of 10455 patientsPhase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia.Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia.Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study.Estrogen receptor β1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker.Expression of Ki-67 nuclear antigen in B and T cell lymphoproliferative disorders.The emerging role of estrogen in B cell malignancies.A prospective study of the evolution of chronic lymphocytic leukaemia.Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo.The impact of gender, age and patient selection on prognosis and outcome in diffuse large B-cell lymphoma - a population-based study.Proliferating cell nuclear antigen (PCNA) expression in chronic lymphocytic leukemia (CLL).Karyotypic and molecular abnormalities in chronic lymphocytic leukaemiaA clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry.Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups.The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative disease.Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia.Morphological and immunophenotypical characterization of Japanese B-cell lymphocytic leukemia.Changes in leukemic cell nuclei revealed by differential scanning calorimetry.Estrogen promotes megakaryocyte polyploidization via estrogen receptor beta-mediated transcription of GATA1.Allogeneic Bone Marrow Transplantation in Chronic Lymphocytic Leukemia: 17 Cases. Report of the EBMT.The Classification of Lymphoid Leukaemias.The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experience
P2860
Q26795818-CF2B491E-CF6E-4872-A02E-9120BEF5F5F4Q28371742-AC287FA1-96BB-4D14-83DB-F57A65682FC3Q33337860-9F3CC5FC-9023-42FB-ADB1-A71738BA8853Q33343670-94E9C428-F865-46CC-ACCE-D691D4CAB032Q33381645-614A22B7-4188-440F-BC52-0A4F289D6662Q33492983-6FC49316-C32E-4489-B2BB-9F2F1505FE4DQ33695983-F175CD29-87A1-4251-BCDB-128A16F61B29Q34206414-F236093B-B962-439A-9764-313B21581DEAQ34257190-64EE8224-86D1-44CA-94E8-156ACCD954D2Q34308997-6E2828CC-81B7-47C9-A516-92F7BF8D1B04Q34702172-1F3146D6-C900-4223-A015-C9D8B819FF1EQ34803868-6F088001-A65D-4C7B-ADFE-400202F8AB61Q34974058-E13FC919-01D3-4085-BD88-D148D127C0D0Q35900933-50B6634F-3F66-4FA5-B881-919125FE3720Q35985600-BA48A8A2-8CC6-44E5-AB68-EBBF02081245Q36590969-79BD09F6-4430-477B-82CA-C050AC5C0991Q37176527-ECE7FF3D-6742-4408-A9D9-53BF7AE03AA6Q37306304-6E8CCFDF-48DA-43F5-89CB-BDB50123EC56Q37489992-F42E7590-1948-4F20-86CE-F26344B66A4FQ37517126-E1100317-EEE9-49D5-B9B9-5F931005D4D6Q37517160-EFA62E5C-15ED-4454-A383-5049C8ECE93FQ37879960-3DB889F8-48AF-4312-BE63-08FFBFC282F0Q38847006-E31096E1-E240-42BD-BE6F-F035D2A1797CQ39401624-ECEB00E2-3988-465C-8815-E876B2C58546Q39456760-AB507791-10F7-411D-B29B-1236CF12BC9CQ39502327-C6EDB22E-9E7A-44C4-A48F-F514172FA341Q39556625-7674F279-8CFD-4F95-A97A-9B856E22B0F7Q40220381-0B6BDCED-BC84-4508-8ECA-03F18259B8F7Q40713786-2A6092B6-AC28-4D43-9310-35169648DE5DQ40849418-A2428830-36CC-4376-A842-24C89B012F75Q41513921-DC7720EB-6F38-44AC-A16B-2A00EEB52DB3Q43187905-74A1E031-F5DA-423C-ABA8-D7F37A2A293CQ43937964-343F96EA-D504-433C-A71D-633FB67701D1Q44896541-C45A5A01-E1DF-4BA4-BC41-34F3DEE03A67Q45083664-92D9B8E2-A90B-4D5F-A9E5-D74D18D898CCQ45204153-942D0D2B-63E3-49F1-B67C-B713825700C5Q51109149-0FC41909-CA79-4AFE-A9AF-A573DBFE4B0FQ54303858-55EBC871-EA7B-4166-9DD6-9DA27C340466Q55241852-3C09CC21-B50B-42A2-87BB-BAB76514077DQ58000962-012919C4-E5C2-4C84-A3E2-AFCB6DCF3791
P2860
Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Prognostic factors in chronic ...... Party on Leukaemia in Adults.
@en
Prognostic factors in chronic ...... Party on Leukaemia in Adults.
@nl
type
label
Prognostic factors in chronic ...... Party on Leukaemia in Adults.
@en
Prognostic factors in chronic ...... Party on Leukaemia in Adults.
@nl
prefLabel
Prognostic factors in chronic ...... Party on Leukaemia in Adults.
@en
Prognostic factors in chronic ...... Party on Leukaemia in Adults.
@nl
P2860
P1476
Prognostic factors in chronic ...... Party on Leukaemia in Adults.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2141.1989.TB07674.X
P407
P577
1989-06-01T00:00:00Z